Policy on plagiarism and self-plagiats
The "ScienceRise: Pharmaceutical Science" does not publish material containing plagiarism or self-plagiarism (duplicate). After being sent to the editor, any manuscript is checked for plagiarism or self-plagiarism by the StrikePlagiarism.com service.
Each case identified is subject to additional analysis to confirm the existence of the fact of proper attribution by the authors of the manuscript. If the fact of lack of proper attribution (plagiarism) is confirmed, the manuscript is rejected without the right to reconsider. If self-plagiarism is found, the manuscript is rejected and a notification is sent to the author that his/her manuscript is not unique enough.
If plagiarism is found after the publication of the article, the article is marked in all indexing resources with the label "PLAGIARISM" or "DUPLICATE", without deleting it from the archive of the journal, where the same label is used. In this case, the editorial board of the journal reserves the right to impose penalties in accordance with the License Agreement between the Licensor (authors) and the Licensee (Publisher) within the framework of the damage caused to the Licensee, both material and moral.